GlassScriptPhysician profile
Christopher John Douglas
NPI 1427251511
$19,508.85
in general payments reported to CMS, 2019-2025
24 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $2,802 · 2021: $820 · 2022: $503 · 2023: $180 · 2024: $435 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,239.10 | 2019-2025 | Supera, Esprit, Cardiomems |
| Novartis Pharmaceuticals Corporation | $926.88 | 2019-2025 | |
| Abiomed | $597.05 | 2019-2021 | |
| Inari Medical, INC. | $410.92 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $311.87 | 2019-2025 | Ranger, Jetstream Sc |
| Chiesi USA, INC. | $164.89 | 2019-2025 | Cleviprex, Kengreal |
| Medtronic Vascular, INC. | $158.50 | 2019-2020 | |
| Edwards Lifesciences Corporation | $105.48 | 2022-2025 | Pascal |
| Cardiva Medical, INC. | $102.10 | 2019-2024 | Savvywire |
| Medtronic, INC. | $92.07 | 2021-2025 | Symplicity G3, Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan |
| Atricure, INC. | $68.29 | 2021 | |
| Livanova USA, INC. | $63.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $41.51 | 2019-2022 | |
| Pfizer INC. | $36.69 | 2019-2021 | |
| Ge Healthcare | $28.95 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $20.44 | 2023 | Verquvo |
| W. L. Gore & Associates, INC. | $20.17 | 2021 | |
| Bracco Diagnostics INC. | $20.07 | 2022 | |
| Philips North America LLC | $19.21 | 2019 | |
| Biosense Webster, INC. | $19.21 | 2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $16.47 | 2025 | Eliquis |
| Stryker Corporation | $16.09 | 2025 | Artix Mt |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.77 | 2021 | |
| Glaxosmithkline, LLC. | $14.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Douglas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.